GLASGOW-based digital chemistry pioneer DeepMatter grew revenues by around 150 per cent in the first half as interest in its technology increased.

The company’s DigitalGlassware product can allow chemists to record information about experiments online for sharing with others.

DeepMatter recorded £0.54 million sales in the six months to June 30, compared with £0.22m in the same period last year.

Losses fell to £1.17m, from £1.62m.

READ MORE: Cancer specialists highlight potential of digital chemistry firm's technology

Chief executive Mark Warne noted the growth reflected steady use of DigitalGlassware among existing customers and the company’s success in winning new clients. He reckons the challenges posed by the Covid 19 coronavirus for organisations operating laboratories has underlined the value of the technology.

“In a world where laboratories are required to be digital, to allow chemists to work in a socially distanced environment resulting from the Covid 19 pandemic, the requirement for DigitalGlassware has accelerated,” he said.

The company concluded agreements with a range of organisations that see potential in its technology in the first half. The agreements have increased confidence in DeepMatter’s growth prospects.

In April the Cancer Research UK Beatson Institute in Glasgow awarded DeepMatter a contract to supply DigitalGlassware for use in the drug discovery process.

READ MORE: Technology pioneer highlights quality of staff available in Glasgow

The universities of Nottingham and Leeds decided to use DigitalGlassware, in teaching work and in support of the development of a robotic laboratory respectively.

Deepmatter raised the prospect that big pharmaceuticals firms that have been assessing Digital Glassware could make increased use of the platform.

It said expansion of scope of DigitalGlassware deployments with top 10 pharma partners is under exploration. Top 10 pharma partners include AstaZeneca and Novartis.

Aim market-listed Deepmatter raised £2.05m, net of expenses, from investors in July. The funding will support increased sales and marketing activity.

The University of Glasgow spin out employs 15 people in the city.

It was founded by Lee Cronin, who is Regius Professor of Chemistry at the university.